221 related articles for article (PubMed ID: 30676743)
1. Interaction of Human Drug-Metabolizing CYP3A4 with Small Inhibitory Molecules.
Sevrioukova I
Biochemistry; 2019 Feb; 58(7):930-939. PubMed ID: 30676743
[TBL] [Abstract][Full Text] [Related]
2. Interaction of CYP3A4 with caffeine: First insights into multiple substrate binding.
Sevrioukova IF
J Biol Chem; 2023 Sep; 299(9):105117. PubMed ID: 37524132
[TBL] [Abstract][Full Text] [Related]
3. Ritonavir analogues as a probe for deciphering the cytochrome P450 3A4 inhibitory mechanism.
Sevrioukova IF; Poulos TL
Curr Top Med Chem; 2014; 14(11):1348-55. PubMed ID: 24805065
[TBL] [Abstract][Full Text] [Related]
4. Structure-Activity Relationships of Rationally Designed Ritonavir Analogues: Impact of Side-Group Stereochemistry, Headgroup Spacing, and Backbone Composition on the Interaction with CYP3A4.
Samuels ER; Sevrioukova I
Biochemistry; 2019 Apr; 58(15):2077-2087. PubMed ID: 30912932
[TBL] [Abstract][Full Text] [Related]
5. Dissecting cytochrome P450 3A4-ligand interactions using ritonavir analogues.
Sevrioukova IF; Poulos TL
Biochemistry; 2013 Jul; 52(26):4474-81. PubMed ID: 23746300
[TBL] [Abstract][Full Text] [Related]
6. Differential Reversible and Irreversible Interactions between Benzbromarone and Human Cytochrome P450s 3A4 and 3A5.
Tang LWT; Verma RK; Yong RP; Li X; Wang L; Lin Q; Fan H; Chan ECY
Mol Pharmacol; 2021 Sep; 100(3):224-236. PubMed ID: 34210765
[TBL] [Abstract][Full Text] [Related]
7. Binding free energies of inhibitors to iron porphyrin complex as a model for Cytochrome P450.
Lee JY; Kang NS; Kang YK
Biopolymers; 2012 Apr; 97(4):219-28. PubMed ID: 22113809
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone.
Williams PA; Cosme J; Vinkovic DM; Ward A; Angove HC; Day PJ; Vonrhein C; Tickle IJ; Jhoti H
Science; 2004 Jul; 305(5684):683-6. PubMed ID: 15256616
[TBL] [Abstract][Full Text] [Related]
9. Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.
Kaur P; Chamberlin AR; Poulos TL; Sevrioukova IF
J Med Chem; 2016 May; 59(9):4210-20. PubMed ID: 26371436
[TBL] [Abstract][Full Text] [Related]
10. Flexible structure of cytochrome P450: promiscuity of ligand binding in the CYP3A4 heme pocket.
Ohkura K; Kawaguchi Y; Watanabe Y; Masubuchi Y; Shinohara Y; Hori H
Anticancer Res; 2009 Mar; 29(3):935-42. PubMed ID: 19414330
[TBL] [Abstract][Full Text] [Related]
11. Molecular Dynamics Simulation Framework to Probe the Binding Hypothesis of CYP3A4 Inhibitors.
Kiani YS; Ranaghan KE; Jabeen I; Mulholland AJ
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510073
[TBL] [Abstract][Full Text] [Related]
12. High-Level Production and Properties of the Cysteine-Depleted Cytochrome P450 3A4.
Sevrioukova IF
Biochemistry; 2017 Jun; 56(24):3058-3067. PubMed ID: 28590129
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Antifungal Azole Interactions with Adult Cytochrome P450 3A4 versus Neonatal Cytochrome P450 3A7.
Godamudunage MP; Grech AM; Scott EE
Drug Metab Dispos; 2018 Sep; 46(9):1329-1337. PubMed ID: 29991575
[TBL] [Abstract][Full Text] [Related]
14. Interaction of human cytochrome P4503A4 with ritonavir analogs.
Sevrioukova IF; Poulos TL
Arch Biochem Biophys; 2012 Apr; 520(2):108-16. PubMed ID: 22410611
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic Studies of Cytochrome P450 3A4 Time-Dependent Inhibition Using Two Cysteine-Targeting Electrophiles.
Barr JT; Wang Z; Min X; Wienkers HJ; Rock BM; Rock DA; Wienkers LC
Drug Metab Dispos; 2020 Jun; 48(6):508-514. PubMed ID: 32193357
[TBL] [Abstract][Full Text] [Related]
16. Clobetasol Propionate Is a Heme-Mediated Selective Inhibitor of Human Cytochrome P450 3A5.
Wright WC; Chenge J; Wang J; Girvan HM; Yang L; Chai SC; Huber AD; Wu J; Oladimeji PO; Munro AW; Chen T
J Med Chem; 2020 Feb; 63(3):1415-1433. PubMed ID: 31965799
[TBL] [Abstract][Full Text] [Related]
17. The X-Ray Crystal Structure of the Human Mono-Oxygenase Cytochrome P450 3A5-Ritonavir Complex Reveals Active Site Differences between P450s 3A4 and 3A5.
Hsu MH; Savas U; Johnson EF
Mol Pharmacol; 2018 Jan; 93(1):14-24. PubMed ID: 29093019
[TBL] [Abstract][Full Text] [Related]
18. N-Heterocyclic Carbene Capture by Cytochrome P450 3A4.
Jennings GK; Ritchie CM; Shock LS; Lyons CE; Hackett JC
Mol Pharmacol; 2016 Jul; 90(1):42-51. PubMed ID: 27126611
[TBL] [Abstract][Full Text] [Related]
19. Interaction of CYP3A4 with Rationally Designed Ritonavir Analogues: Impact of Steric Constraints Imposed on the Heme-Ligating Group and the End-Pyridine Attachment.
Samuels ER; Sevrioukova IF
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806297
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Human CYP3A4 by Rationally Designed Ritonavir-Like Compounds: Impact and Interplay of the Side Group Functionalities.
Samuels ER; Sevrioukova I
Mol Pharm; 2018 Jan; 15(1):279-288. PubMed ID: 29232137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
